JP2006506073A - 組織培養に基づく発現プロファイリング - Google Patents
組織培養に基づく発現プロファイリング Download PDFInfo
- Publication number
- JP2006506073A JP2006506073A JP2004552178A JP2004552178A JP2006506073A JP 2006506073 A JP2006506073 A JP 2006506073A JP 2004552178 A JP2004552178 A JP 2004552178A JP 2004552178 A JP2004552178 A JP 2004552178A JP 2006506073 A JP2006506073 A JP 2006506073A
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- rna
- expression
- cdna
- crna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1072—Differential gene expression library synthesis, e.g. subtracted libraries, differential screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Bioinformatics & Computational Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本願は、2002年11月12日出願の米国出願番号US60/425945に対する35 U.S.C. § 119(e)下での恩恵を主張するものである。その出願の内容は、参照によって本明細書に組み込まれる。
Claims (10)
- 組織の発現プロファイルを作成する方法であって、三次元コラーゲンスポンジ−ゲル培養基中で培養した前記組織の無傷サンプルからRNAを抽出する段階を含む方法。
- 前記RNAの分析を行って発現データを得ることをさらに含む請求項1に記載の方法。
- 前記抽出されたRNAをcDNAに変換することをさらに含む請求項1に記載の方法。
- 前記cDNAから標識cRNAを製造すること;ならびに
前記cRNAをマイクロアレイ分析を用いて分析すること
をさらに含む請求項3に記載の方法。 - 前記組織が腫瘍組織である請求項1に記載の方法。
- 前記組織が、乳房、肺、結腸、肝臓、胃、膵臓、前立腺、頭部、頸部、卵巣または脳のものである請求項5に記載の方法。
- 請求項1に記載の方法によって得られるRNA発現ライブラリ。
- 請求項3に記載の方法によって得られるcDNA発現ライブラリ。
- 請求項4に記載の方法によって得られるcRNA発現ライブラリ。
- 前記データに基づいて予後の準備することをさらに含む請求項2に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42594502P | 2002-11-12 | 2002-11-12 | |
PCT/US2003/036238 WO2004044177A2 (en) | 2002-11-12 | 2003-11-12 | Expression profiling based on histocultures |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2006506073A true JP2006506073A (ja) | 2006-02-23 |
JP4336654B2 JP4336654B2 (ja) | 2009-09-30 |
Family
ID=32313081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004552178A Expired - Fee Related JP4336654B2 (ja) | 2002-11-12 | 2003-11-12 | 組織培養に基づく発現プロファイリング |
Country Status (10)
Country | Link |
---|---|
US (2) | US7252941B2 (ja) |
EP (1) | EP1567672B1 (ja) |
JP (1) | JP4336654B2 (ja) |
KR (1) | KR101142716B1 (ja) |
CN (1) | CN100572557C (ja) |
AT (1) | ATE429514T1 (ja) |
AU (1) | AU2003294267B2 (ja) |
CA (1) | CA2505895C (ja) |
DE (1) | DE60327359D1 (ja) |
WO (1) | WO2004044177A2 (ja) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5726009A (en) | 1989-03-20 | 1998-03-10 | Anticancer, Inc. | Native-state method and system for determining viability and proliferative capacity of tissues in vitro |
WO1995001455A1 (en) | 1993-06-29 | 1995-01-12 | Anticancer, Inc. | NATIVE-STATE METHOD AND SYSTEM FOR DETERMINING VIABILITY AND PROLIFERATIVE CAPACITY OF TISSUES $i(IN VITRO) |
DE69228055T2 (de) | 1991-02-28 | 1999-05-20 | Anticancer Inc | Ein gewebekulturverfahren für haut im natürlichen zustand |
US5474909A (en) * | 1992-08-07 | 1995-12-12 | Anticancer, Inc. | Noncolorimetric histoculture method for predicting drug response of tumors |
US6203984B1 (en) | 1998-07-02 | 2001-03-20 | Pacron, Inc. | Proportional amplification of mRNA from a linear template in vitro |
-
2003
- 2003-11-12 AU AU2003294267A patent/AU2003294267B2/en not_active Ceased
- 2003-11-12 EP EP20030789749 patent/EP1567672B1/en not_active Expired - Lifetime
- 2003-11-12 DE DE60327359T patent/DE60327359D1/de not_active Expired - Lifetime
- 2003-11-12 JP JP2004552178A patent/JP4336654B2/ja not_active Expired - Fee Related
- 2003-11-12 US US10/712,781 patent/US7252941B2/en not_active Expired - Fee Related
- 2003-11-12 KR KR20057008544A patent/KR101142716B1/ko active IP Right Grant
- 2003-11-12 WO PCT/US2003/036238 patent/WO2004044177A2/en active Application Filing
- 2003-11-12 CA CA 2505895 patent/CA2505895C/en not_active Expired - Fee Related
- 2003-11-12 AT AT03789749T patent/ATE429514T1/de not_active IP Right Cessation
- 2003-11-12 CN CNB2003801086762A patent/CN100572557C/zh not_active Expired - Fee Related
-
2007
- 2007-08-07 US US11/835,382 patent/US20080058222A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2003294267A1 (en) | 2004-06-03 |
EP1567672A2 (en) | 2005-08-31 |
KR101142716B1 (ko) | 2012-05-04 |
CA2505895C (en) | 2013-10-22 |
KR20050063805A (ko) | 2005-06-28 |
CN1738910A (zh) | 2006-02-22 |
WO2004044177A2 (en) | 2004-05-27 |
JP4336654B2 (ja) | 2009-09-30 |
EP1567672B1 (en) | 2009-04-22 |
US20040229234A1 (en) | 2004-11-18 |
CA2505895A1 (en) | 2004-05-27 |
AU2003294267B2 (en) | 2009-01-08 |
EP1567672A4 (en) | 2006-08-16 |
US7252941B2 (en) | 2007-08-07 |
US20080058222A1 (en) | 2008-03-06 |
WO2004044177A3 (en) | 2005-03-17 |
ATE429514T1 (de) | 2009-05-15 |
CN100572557C (zh) | 2009-12-23 |
DE60327359D1 (de) | 2009-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20070105142A1 (en) | Methods for prognosis and monitoring cancer therapy | |
US20100261617A1 (en) | Gene expression signature for the prognosis, diagnosis, and therapy of prostate cancer and uses thereof | |
AU2013281355B2 (en) | Targeted RNA-seq methods and materials for the diagnosis of prostate cancer | |
KR20080065476A (ko) | 폐암 환자 또는 폐암 치료를 받은 폐암 환자에 대한 폐암재발의 위험을 예측하는 방법, 폐암 환자 또는 폐암 치료를받은 환자의 폐암 재발 위험성에 대한 보고서를 작성하는방법, 그에 의하여 작성된 보고서, 폐암 환자 또는 폐암치료를 받은 폐암 환자의 폐암 재발 위험을 진단하기 위한조성물, 키트 및 마이크로어레이 | |
WO2005076005A2 (en) | A method for classifying a tumor cell sample based upon differential expression of at least two genes | |
WO2011086174A2 (en) | Diagnostic gene expression platform | |
JP2015043781A (ja) | 不妊症および/または卵の質を評価するための方法および装置 | |
JP2007236253A (ja) | 疾患又は疾患マーカーの検出方法 | |
US20120004127A1 (en) | Gene expression markers for colorectal cancer prognosis | |
Grisaru et al. | Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings | |
Hicks et al. | In situ hybridization in the pathology laboratory: general principles, automation, and emerging research applications for tissue-based studies of gene expression | |
KR20030078801A (ko) | 결장직장암의 검사방법 | |
JP4336654B2 (ja) | 組織培養に基づく発現プロファイリング | |
KR20030078802A (ko) | 결장직장암의 검사방법 | |
He et al. | Cancer development and progression | |
Odani et al. | Gene expression profiles of oral leukoplakia and carcinoma: genome-wide comparison analysis using oligonucleotide microarray technology | |
JP2006166789A (ja) | 癌の新規診断方法 | |
AU2014202370B2 (en) | Gene Expression Profiles to Predict Breast Cancer Outcomes | |
Pusztai | Perspectives and challenges of clinical pharmacogenomics in cancer | |
EP2039780A1 (en) | Single-readout multiplexing of metagenes | |
EP2389450B1 (en) | Methods for determining a prognosis for survival for a patient with breast cancer | |
KUMAVATH et al. | Trends in Gene Expression Profiling: An Overview of Challenges for Cancer Diagnosis | |
JP2007274926A (ja) | 大腸癌検査方法、そのためのプライマー及びキット | |
Basso et al. | Gene expression profile analysis of lymphomas | |
JP2008178362A (ja) | 新規癌検出方法、癌検出器具、および癌検出キット |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20051227 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080304 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080529 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080605 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080904 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20081007 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090105 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090113 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090206 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090310 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20090508 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090602 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090629 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120703 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20120702 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130703 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130703 Year of fee payment: 4 |
|
RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: R3D03 |
|
A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A072 Effective date: 20121031 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |